Multicenter evaluation of the safety, tolerance, and efficacy of OptiMARK in magnetic resonance imaging of the brain and spine

Acad Radiol. 1998 Apr:5 Suppl 1:S154-5; discussion S156. doi: 10.1016/s1076-6332(98)80089-5.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain / pathology*
  • Contrast Media* / administration & dosage
  • Contrast Media* / adverse effects
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Gadolinium* / administration & dosage
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Organometallic Compounds* / administration & dosage
  • Organometallic Compounds* / adverse effects
  • Spine / pathology*

Substances

  • Contrast Media
  • Organometallic Compounds
  • Gadolinium
  • gadoversetamide